Article info
PDFClinical alert
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis
Citation
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis
Publication history
- First published April 1, 1999.
Online issue publication
February 14, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
British Society of Gastroenterology